Drugs / DR-1011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00196326 | Jun 2005 → Jun 2007 | — | Duramed Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DR-1011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00196326 ↗ |
| Route | Oral | “Participants were instructed to take, by mouth, one tablet daily for four 91-day cycles.” NCT00196326 ↗ |